Business Description
Founded in Shanghai in 2017, Mabwell Bioscience is a Chinese biopharmaceutical company that develops, manufactures, and sells biological medicines for a wide range of serious conditions, including cancer, immune disorders, bone disease, eye conditions, blood disorders, and infectious diseases. The company already sells several approved products, such as treatments for bone tumors, osteoporosis, and autoimmune conditions, while also advancing a deep pipeline of experimental therapies in various stages of clinical testing. Many of its pipeline candidates target cancer through antibody-drug conjugate technology, and others address conditions such as chronic obstructive pulmonary disease, age-related macular degeneration, and inherited blood disorders. Mabwell serves both the domestic Chinese market and international customers.
